Literature DB >> 1828136

Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice.

B Ji1, E G Perani, J H Grosset.   

Abstract

As determined by the proportional bactericide method, clarithromycin had strong bactericidal activity against Mycobacterium leprae. Clarithromycin was administered to mice by gavage as 20 daily doses at dosages of 12.5 to 50 mg/kg of body weight. At a dosage of 25 mg/kg, minocycline was more active than clarithromycin at a dosage of 50 mg/kg. Additive effects were displayed with the combination of clarithromycin (50 mg/kg) and minocycline (25 mg/kg), both of which were administered daily by gavage, and of clarithromycin and minocycline, both of which were administered daily by gavage at dosages of 25 mg/kg each, with rifampin at a single oral dose of 10 mg/kg.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1828136      PMCID: PMC245054          DOI: 10.1128/AAC.35.3.579

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

Review 1.  Recent advances in the chemotherapy of leprosy.

Authors:  B Ji; J H Grosset
Journal:  Lepr Rev       Date:  1990-12       Impact factor: 0.537

2.  Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.

Authors:  J H Grosset; B H Ji; C C Guelpa-Lauras; E G Perani; L N N'Deli
Journal:  Int J Lepr Other Mycobact Dis       Date:  1990-06

3.  In vitro and in vivo activities of macrolides against Mycobacterium leprae.

Authors:  S G Franzblau; R C Hastings
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

4.  Activity of minocycline in Mycobacterium leprae-infected mice.

Authors:  R H Gelber
Journal:  J Infect Dis       Date:  1987-07       Impact factor: 5.226

5.  Rapid bactericidal effect of rifampin on Mycobacterium leprae.

Authors:  C C Shepard; L Levy; P Fasal
Journal:  Am J Trop Med Hyg       Date:  1972-07       Impact factor: 2.345

6.  Pharmacokinetic studies on minocycline in man.

Authors:  H Macdonald; R G Kelly; E S Allen; J F Noble; L A Kanegis
Journal:  Clin Pharmacol Ther       Date:  1973 Sep-Oct       Impact factor: 6.875

Review 7.  Screening of drugs for activity against Mycobacterium leprae.

Authors:  J Baohong; Y Matsuo; M J Colston
Journal:  Int J Lepr Other Mycobact Dis       Date:  1987-12

8.  Statistical analysis of results obtained by two methods for testing drug activity against Mycobacterium leprae.

Authors:  C C Shepard
Journal:  Int J Lepr Other Mycobact Dis       Date:  1982-03

9.  Drug susceptibility testing of Mycobacterium leprae in the BACTEC 460 system.

Authors:  S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

  9 in total
  26 in total

Review 1.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

2.  Development of rifapentine susceptibility tests for Mycobacterium tuberculosis.

Authors:  L Heifets; T Sanchez; J Vanderkolk; V Pham
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

3.  Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice.

Authors:  Herve Dega; Abdelhalim Bentoucha; Jerome Robert; Vincent Jarlier; Jacques Grosset
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

4.  Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model.

Authors:  B Ji; N Lounis; C Truffot-Pernot; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

5.  Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice.

Authors:  T Lazard; C Perronne; Y Cohen; J Grosset; J L Vilde; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

6.  Clinical trial of clarithromycin for lepromatous leprosy.

Authors:  G P Chan; B Y Garcia-Ignacio; V E Chavez; J B Livelo; C L Jimenez; M L Parrilla; S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

7.  In vitro activities of aminoglycosides, lincosamides, and rifamycins against Mycobacterium leprae.

Authors:  S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

8.  Activities of various quinolone antibiotics against Mycobacterium leprae in infected mice.

Authors:  R H Gelber; A Iranmanesh; L Murray; P Siu; M Tsang
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

9.  Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages.

Authors:  Y Cohen; C Perronne; C Truffot-Pernot; J Grosset; J L Vilde; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

10.  Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium.

Authors:  T Lazard; C Perronne; J Grosset; J L Vilde; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.